204 related articles for article (PubMed ID: 26290450)
21. p38α MAPK pathway: a key factor in colorectal cancer therapy and chemoresistance.
Grossi V; Peserico A; Tezil T; Simone C
World J Gastroenterol; 2014 Aug; 20(29):9744-58. PubMed ID: 25110412
[TBL] [Abstract][Full Text] [Related]
22. SIRT1 promotes the progression and chemoresistance of colorectal cancer through the p53/miR-101/KPNA3 axis.
Wang XW; Jiang YH; Ye W; Shao CF; Xie JJ; Li X
Cancer Biol Ther; 2023 Dec; 24(1):2235770. PubMed ID: 37575080
[TBL] [Abstract][Full Text] [Related]
23. Gypenosides Synergistically Enhances the Anti-Tumor Effect of 5-Fluorouracil on Colorectal Cancer In Vitro and In Vivo: A Role for Oxidative Stress-Mediated DNA Damage and p53 Activation.
Kong L; Wang X; Zhang K; Yuan W; Yang Q; Fan J; Wang P; Liu Q
PLoS One; 2015; 10(9):e0137888. PubMed ID: 26368019
[TBL] [Abstract][Full Text] [Related]
24. Epigenetically Down-Regulated Acetyltransferase PCAF Increases the Resistance of Colorectal Cancer to 5-Fluorouracil.
Liu T; Wang X; Hu W; Fang Z; Jin Y; Fang X; Miao QR
Neoplasia; 2019 Jun; 21(6):557-570. PubMed ID: 31042625
[TBL] [Abstract][Full Text] [Related]
25. LIM domain-containing protein Ajuba inhibits chemotherapy-induced apoptosis by negatively regulating p53 stability in colorectal cancer cells.
Xu B; Li Q; Zhang J; Chen F
Mol Oncol; 2023 Aug; 17(8):1678-1691. PubMed ID: 36931700
[TBL] [Abstract][Full Text] [Related]
26. Veliparib (ABT-888), a PARP inhibitor potentiates the cytotoxic activity of 5-fluorouracil by inhibiting MMR pathway through deregulation of MSH6 in colorectal cancer stem cells.
Paul S; Chatterjee S; Sinha S; Dash SR; Pradhan R; Das B; Goutam K; Kundu CN
Expert Opin Ther Targets; 2023; 27(10):999-1015. PubMed ID: 37787493
[TBL] [Abstract][Full Text] [Related]
27. 5-FU promotes stemness of colorectal cancer via p53-mediated WNT/β-catenin pathway activation.
Cho YH; Ro EJ; Yoon JS; Mizutani T; Kang DW; Park JC; Il Kim T; Clevers H; Choi KY
Nat Commun; 2020 Oct; 11(1):5321. PubMed ID: 33087710
[TBL] [Abstract][Full Text] [Related]
28. CDK-dependent phosphorylation of PHD1 on serine 130 alters its substrate preference in cells.
Ortmann B; Bensaddek D; Carvalhal S; Moser SC; Mudie S; Griffis ER; Swedlow JR; Lamond AI; Rocha S
J Cell Sci; 2016 Jan; 129(1):191-205. PubMed ID: 26644182
[TBL] [Abstract][Full Text] [Related]
29. P38MAPK is a major determinant of the balance between apoptosis and autophagy triggered by 5-fluorouracil: implication in resistance.
de la Cruz-Morcillo MA; Valero ML; Callejas-Valera JL; Arias-González L; Melgar-Rojas P; Galán-Moya EM; García-Gil E; García-Cano J; Sánchez-Prieto R
Oncogene; 2012 Mar; 31(9):1073-85. PubMed ID: 21841826
[TBL] [Abstract][Full Text] [Related]
30. PHD3 Regulates p53 Protein Stability by Hydroxylating Proline 359.
Rodriguez J; Herrero A; Li S; Rauch N; Quintanilla A; Wynne K; Krstic A; Acosta JC; Taylor C; Schlisio S; von Kriegsheim A
Cell Rep; 2018 Jul; 24(5):1316-1329. PubMed ID: 30067985
[TBL] [Abstract][Full Text] [Related]
31. Chronic exposure of colorectal cancer cells in culture to fluoropyrimidine analogs induces thymidylate synthase and suppresses p53. A molecular explanation for the mechanism of 5-FU resistance.
Subbarayan PR; Sarkar M; Nelson G; Benitez E; Singhal S; Ardalan B
Anticancer Res; 2010 Apr; 30(4):1149-56. PubMed ID: 20530421
[TBL] [Abstract][Full Text] [Related]
32. Targeting the miR-34a/LRPPRC/MDR1 axis collapse the chemoresistance in P53 inactive colorectal cancer.
Yang Y; Yuan H; Zhao L; Guo S; Hu S; Tian M; Nie Y; Yu J; Zhou C; Niu J; Wang G; Song Y
Cell Death Differ; 2022 Nov; 29(11):2177-2189. PubMed ID: 35484333
[TBL] [Abstract][Full Text] [Related]
33. CTCF promotes colorectal cancer cell proliferation and chemotherapy resistance to 5-FU via the P53-Hedgehog axis.
Lai Q; Li Q; He C; Fang Y; Lin S; Cai J; Ding J; Zhong Q; Zhang Y; Wu C; Wang X; He J; Liu Y; Yan Q; Li A; Liu S
Aging (Albany NY); 2020 Jul; 12(16):16270-16293. PubMed ID: 32688344
[TBL] [Abstract][Full Text] [Related]
34. Pseudolaric acid B induces mitotic arrest and apoptosis in both 5-fluorouracil-sensitive and -resistant colorectal cancer cells.
Wen C; Chen J; Zhang D; Wang H; Che J; Qin Q; He L; Cai Z; Lin M; Lou Q; Huang L; Chen D; Iwamoto A; Ren D; Wang L; Lan P; Wang J; Liu H; Yang X
Cancer Lett; 2016 Dec; 383(2):295-308. PubMed ID: 27713084
[TBL] [Abstract][Full Text] [Related]
35. Combination of Compound Kushen Injection and cisplatin shows synergistic antitumor activity in p53-R273H/P309S mutant colorectal cancer cells through inducing apoptosis.
Wu X; Lu Y; Qin X
J Ethnopharmacol; 2022 Jan; 283():114690. PubMed ID: 34597653
[TBL] [Abstract][Full Text] [Related]
36. The c-MYC-WDR43 signalling axis promotes chemoresistance and tumour growth in colorectal cancer by inhibiting p53 activity.
Di Y; Jing X; Hu K; Wen X; Ye L; Zhang X; Qin J; Ye J; Lin R; Wang Z; He W
Drug Resist Updat; 2023 Jan; 66():100909. PubMed ID: 36525936
[TBL] [Abstract][Full Text] [Related]
37. Cooperation of SRPK2, Numb and p53 in the malignant biology and chemosensitivity of colorectal cancer.
Wang G; Sheng W; Tang J; Li X; Zhou J; Dong M
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31898732
[TBL] [Abstract][Full Text] [Related]
38. Verbascoside promotes apoptosis by regulating HIPK2-p53 signaling in human colorectal cancer.
Zhou L; Feng Y; Jin Y; Liu X; Sui H; Chai N; Chen X; Liu N; Ji Q; Wang Y; Li Q
BMC Cancer; 2014 Oct; 14():747. PubMed ID: 25282590
[TBL] [Abstract][Full Text] [Related]
39. β-Sitosterol Reverses Multidrug Resistance via BCRP Suppression by Inhibiting the p53-MDM2 Interaction in Colorectal Cancer.
Wang Z; Zhan Y; Xu J; Wang Y; Sun M; Chen J; Liang T; Wu L; Xu K
J Agric Food Chem; 2020 Mar; 68(12):3850-3858. PubMed ID: 32167760
[TBL] [Abstract][Full Text] [Related]
40. Villosol reverses 5-FU resistance in colorectal cancer by inhibiting the CDKN2A gene regulated TP53-PI3K/Akt signaling axis.
Chen H; Deng J; Hou TW; Shan YQ
J Ethnopharmacol; 2024 May; 325():117907. PubMed ID: 38342156
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
